Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study

Charlotte K Ekelund1, Finn Stener Jørgensen, Olav Bjørn Petersen

  • 1Department of Fetal Medicine, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.

BMJ (Clinical Research Ed.)
|November 29, 2008
PubMed

Insights

A new first-trimester screening strategy in Denmark significantly reduced Down

Area of Science:

  • Prenatal diagnostics and screening
  • Fetal medicine and obstetrics
  • Genetics and congenital disorders

Background:

  • Down's syndrome screening has evolved with advancements in prenatal diagnostic techniques.
  • First-trimester screening offers an early opportunity for risk assessment.
  • Denmark implemented a national first-trimester screening strategy to improve outcomes.

Purpose of the Study:

  • To assess the impact of Denmark's first-trimester screening strategy (2004-2006) on Down's syndrome births.
  • To evaluate changes in chorionic villus sampling (CVS) and amniocentesis rates.
  • To determine detection and false positive rates for the screening program.

Main Methods:

  • Population-based cohort study involving 19 Danish departments.
  • Analysis of data from 65,000 pregnancies annually between 2000-2007.
  • Primary outcomes: Down's syndrome diagnoses (prenatal/postnatal), CVS, and amniocentesis numbers.

Main Results:

  • Infants born with Down's syndrome decreased from 55-65 annually (2000-2004) to 31 (2005) and 32 (2006).
  • Total CVS and amniocenteses dropped from 7524 (2000) to 3510 (2006).
  • Detection rates were 86% (2005) and 93% (2006); false positive rates were 3.9% (2005) and 3.3% (2006).

Conclusions:

  • National first-trimester screening in Denmark effectively halved the number of infants born with Down's syndrome.
  • The strategy significantly reduced invasive procedures like CVS and amniocentesis.
  • Early implementation of the policy demonstrated substantial positive impacts on public health.
Abstract